The Oncology Institute, Inc. (TOI)

NASDAQ: TOI · IEX Real-Time Price · USD

1.150

-0.030 (-2.54%)

At close: Apr 26, 2024, 4:00 PM

1.160

+0.010 (0.87%)

After-hours: Apr 26, 2024, 6:53 PM EDT

The Oncology Institute Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-67.88	0.07	-10.63	-14.32	-4.02
Depreciation & Amortization	5.87	4.41	3.34	3.18	2.94
Share-Based Compensation	17.81	27.68	24.54	0.15	0.09
Other Operating Activities	7.88	-93.92	-49.93	11.5	4.6
Operating Cash Flow	-36.32	-61.76	-32.68	0.51	3.62
Operating Cash Flow Growth	-	-	-	-85.95%	-
Capital Expenditures	-4.57	-5.53	-2.85	-1.19	-1.2
Acquisitions	-4.46	-8.58	-9.31	-0.15	0
Change in Investments	71.66	-117.51	0	-7.5	0
Investing Cash Flow	62.64	-131.61	-12.15	-8.84	-1.2
Share Issuance / Repurchase	-0.89	-8.14	333.95	0.05	0
Debt Issued / Paid	-3.37	101.27	0.77	12.18	-0
Other Financing Activities	-2.58	-0.92	-180.71	-0.34	-
Financing Cash Flow	-6.85	92.21	154.01	11.89	-0
Net Cash Flow	19.48	-101.16	109.18	3.55	2.41
Free Cash Flow	-40.88	-67.29	-35.53	-0.69	2.41
Free Cash Flow Margin	-12.61%	-26.65%	-17.50%	-0.37%	1.55%
Free Cash Flow Per Share	-0.55	-0.92	-0.54	-0.01	0.24

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).